Insiders Advisor
  • Stocks
  • World News
  • Business
  • Politics
  • Stocks
  • World News
  • Business
  • Politics

Insiders Advisor

Politics

Former Biden doctor asks to delay testimony to House committee investigating mental fitness

by July 8, 2025
July 8, 2025
Former Biden doctor asks to delay testimony to House committee investigating mental fitness

Former White House physician Kevin O’Connor, who served as doctor to former President Joe Biden, requested a delay to his upcoming testimony before the House Oversight Committee this week.

O’Connor was scheduled to testify on Wednesday, but is now in a disagreement with the committee over the scope of the questions he will be expected to answer during his testimony. The committee, led by Chairman James Comer, R-Ky., is interviewing the doctor as part of its investigation into Biden’s mental fitness and his administration’s use of an autopen.

A lawyer for O’Connor requested the testimony be delayed to July 28 or August 4 in a letter to Comer.

‘Dr. O’Connor has legal and ethical obligations that he must satisfy and for which violations carry serious consequences to him professionally and personally,’ the letter says.

‘We are unaware of any prior occasion on which a Congressional Committee has subpoenaed a physician to testify about the treatment of an individual patient.  And the notion that a Congressional Committee would do so without any regard whatsoever for the confidentiality of the physician-patient relationship is alarming.’

A spokesman for the Oversight Committee replied in a statement that O’Connor and his legal team were merely trying to ‘stonewall’ the process. The committee is planning to move forward with Wednesday’s testimony, which O’Connor faces a subpoena to attend.

The committee said O’Connor is welcome to object to individual questions during his testimony. But O’Connor is not allowed, in the committee’s view, to delay or decline a congressional subpoena due to concerns over questions about potentially privileged information.

The debate over O’Connor’s testimony comes weeks after a former top aide to Biden, Neera Tanden, told the Oversight Committee that she was authorized to direct autopen signatures but was unaware of who in the president’s inner circle was giving her final clearance.

During Tanden’s interview before Congress last month, which lasted more than five hours, she told lawmakers that, in her role as staff secretary and senior advisor to the former president between 2021 and 2023, she was authorized to direct autopen signatures on behalf of Biden, an Oversight Committee official told Fox News.

‘Ms. Tanden testified that she had minimal interaction with President Biden, despite wielding tremendous authority,’ Comer said at the time. ‘She explained that to obtain approval for autopen signatures, she would send decision memos to members of the President’s inner circle and had no visibility of what occurred between sending the memo and receiving it back with approval. Her testimony raises serious questions about who was really calling the shots in the Biden White House amid the President’s obvious decline. We will continue to pursue the truth for the American people.’

Fox News’ Kelly Phares and Madeleine Rivera and the Associated Press contributed to this report.

This post appeared first on FOX NEWS
previous post
Trump and Netanyahu celebrate ‘historic victory’ against Iran, eye future Middle East peace
next post
US will ‘have to’ send weapons to Ukraine, Trump says days after Pentagon pause

Related Posts

AI security infrastructure needed after ‘malicious’ foreign actors...

February 17, 2024

Trump takes jab at GOP senator, urging Republicans...

August 1, 2025

Trump to sign executive order establishing White House...

February 7, 2025

Harris’ cold open appears to copy Trump’s 2015...

November 3, 2024

DOGE USAID budget cuts hit UN in ‘worst...

March 22, 2025

Senate DOGE Republican pushes bill to bring government...

February 6, 2025

Theme of Trump’s address to Congress revealed

March 4, 2025

Planned Parenthood appears to scrub Instagram as fears...

February 15, 2025

Biden travels to Africa where policies were ‘over-promised...

December 2, 2024

Gabbard says Comey should be ‘put behind bars’...

May 16, 2025

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest News

    • Crop tour projects record 2025 U.S. corn harvest, but disease could hit yields

      August 23, 2025
    • FBI raid of John Bolton’s home reportedly linked to classified documents probe

      August 23, 2025
    • The history of how Trump and Bolton’s relationship fell to tatters

      August 23, 2025
    • Cracker Barrel CEO serves up leftover corporate branding to unhappy customers

      August 23, 2025
    • GOP senators push Kamala Harris testimony as House Oversight eyes subpoena

      August 23, 2025
    • 10 key takeaways from DOJ’s release of Ghislaine Maxwell’s Epstein interviews

      August 23, 2025

    Categories

    • Business (1,358)
    • Politics (6,831)
    • Stocks (904)
    • World News (461)
    • About us
    • Contacts
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: insidersadvisor.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 insidersadvisor.com | All Rights Reserved